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Article
Distinct retrieval and retention mechanisms
are required for the quality control of
endoplasmic reticulum protein folding
Shilpa Vashist,1 Woong Kim,1 William J. Belden,2 Eric D. Spear,1 Charles Barlowe,2 and Davis T.W. Ng1
1
2

Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA 16802
Department of Biochemistry, Dartmouth Medical School, Hanover, NH 03755

P

roteins destined for the secretory pathway must first
fold and assemble in the lumen of endoplasmic
reticulum (ER). The pathway maintains a quality control
mechanism to assure that aberrantly processed proteins are
not delivered to their sites of function. As part of this
mechanism, misfolded proteins are returned to the cytosol
via the ER protein translocation pore where they are ubiquitinated and degraded by the 26S proteasome. Previously,
little was known regarding the recognition and targeting of
proteins before degradation. By tracking the fate of several
mutant proteins subject to quality control, we demonstrate

the existence of two distinct sorting mechanisms. In the ER,
substrates are either sorted for retention in the ER or are
transported to the Golgi apparatus via COPII–coated vesicles.
Proteins transported to the Golgi are retrieved to the ER via
the retrograde transport system. Ultimately, both retained and
retrieved proteins converge at a common machinery at the
ER for degradation. Furthermore, we report the identification
of a gene playing a novel role specific to the retrieval
pathway. The gene, BST1, is required for the transport of
misfolded proteins to the Golgi, although dispensable for
the transport of many normal cargo proteins.

Introduction
Proteins destined for the secretory pathway first pass
through the membranes of the endoplasmic reticulum
(ER)*. To enter the lumen, they traverse a proteinaceous
pore termed the “translocon” (Johnson and van Waes,
1999). Nascent soluble proteins are released into the lumen,
whereas membrane proteins are integrated into the ER
membrane. Since these proteins are translocated in an unfolded
state, assembly into their native conformations occurs as a
subsequent step in the ER. For this, the organelle maintains
an inventory of raw materials, enzymes, and chaperones
needed for proper protein folding and modification. Due to
the localized nature of these functions, a mechanism termed
“ER quality control” prevents transport of newly synthesized
Address correspondence to Davis Ng, Dept. of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA 16802.
Tel.: (814) 863-5686. Fax: (814) 863-5876. E-mail: dtn1@psu.edu
*Abbreviations used in this paper: ALP, alkaline phosphatase; CPS, carboxypeptidase S; CPY, carboxypeptidase Y; ER, endoplasmic reticulum; ERAD, ER-associated protein degradation; HN, hemagglutinin
neuraminidase; PMT, protein mannosyltransferase; SR , signal recognition particle receptor  subunit; UPR, unfolded protein response; VSV-G,
vesicular stomatitis virus G.
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polypeptides to their sites of function until they reach their
native conformation (Ellgaard et al., 1999).
The quality control mechanism also plays important roles
when proteins fail to fold. Misfolded proteins are directed to
a degradative pathway termed ER-associated protein degradation (ERAD) (Sommer and Wolf, 1997; Brodsky and
McCracken, 1999). In this pathway, degradation does not
occur in the lumen of the ER. Instead, proteins are transported back to the cytosol via the same translocon complex
used for import (Wiertz et al., 1996; Pilon et al., 1997;
Plemper et al., 1997; Zhou and Schekman, 1999). The process, termed retrotranslocation or dislocation, is usually coupled to ubiquitination, a requisite covalent modification of
the substrate for degradation (Biederer et al., 1997). Ubiquitination takes place on the cytosolic surface of the ER,
since the E2 and E3 enzymes Ubc7p and Hrd1p/Der3p, respectively, are localized there and may be positioned adjacent
to the translocon (Hiller et al., 1996; Bordallo et al., 1998;
Bays et al., 2001). Once marked, these proteins are rapidly
degraded by the cytosolic 26S proteasome (Hiller et al.,
1996).
Although much is known about the fate of ERAD substrates near the point of degradation, much less is understood
regarding how they are recognized, retained, and targeted to
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the translocation/ubiquitination machinery. One model
emerged that nascent polypeptides remain partially in the
translocon after import. The polypeptide can only be released upon folding, whereas misfolded proteins are retrotranslocated via the same pore. The hypothesis was appealing, since it provided for a simple mechanism for retention
and degradation. The model was brought into question
when a well-established yeast soluble ERAD substrate, a mutant version of carboxypeptidase Y called CPY*, was shown
to be translocated completely across the membrane (Plemper
et al., 1999). However, the observation did not rule out the
possibility that the nascent polypeptide remains associated
with the translocon after translocation.
In mammalian cells, a mutant version of the well-characterized vesicular stomatitis virus G (VSV-G) protein, ts045,
was observed to be localized to the ER of cells shifted to
39.5C, a temperature that causes it to misfold (Kreis and
Lodish, 1986). An elegant study using VSV-G ts045 fused
to the green fluorescent protein provided direct evidence of
an ER retention mechanism. Using photobleaching experiments in live cells, the integral membrane protein was
shown to move freely in the plane of the membrane but did
not leave the ER (Nehls et al., 2000). In cells overexpressing
VSV-G ts045 through prolonged incubation at the restrictive temperature, a fraction of the protein escapes the ER
and gets transported to the Golgi and retrieved (Hammond
and Helenius, 1994). Although these earlier experiments
were performed under more extreme conditions, they left
open the possibility of a recycling mechanism for misfolded
proteins. In yeast, the mechanism is less clear, but the efficient degradation of mutant versions of Ste6p and Yor1p integral membrane proteins in absence of ER-to-Golgi transport seems to support the mammalian view (Loayza et al.,
1998; Katzmann et al., 1999).
A common quality control mechanism for both misfolded
soluble and membrane proteins presents a spatial problem,
since these two classes may occupy distinct regions of the ER
(that is, luminal versus membrane). Therefore, it is plausible
that different recognition and targeting mechanisms exist to
direct the proteins into the degradation pathway. In this
view, the ubiquitin/proteasome pathway used by both misfolded soluble and membrane proteins can be thought of either as an endpoint for an ER retention mechanism or a
point of convergence for distinct mechanisms.
In this study, we examined the fate of several quality control
substrates subject to ERAD-specific degradation in the budding yeast Saccharomyces cerevisiae. We demonstrate the coexistence of retention and retrieval mechanisms that define distinct classes of quality control substrates. For both pathways, a
sorting step occurs in the ER whereby substrates of the retrieval pathway are packaged into COPII transport vesicles,
whereas those to be retained are excluded. Furthermore, by
using a genetic approach we’ve isolated mutants dissecting the
two pathways. We report a mutant allele of the gene BST1
called per17–1 that prevents the ER-to-Golgi transport of
misfolded proteins while preserving the transport of most normal proteins. In per17–1 cells, quality control is disrupted at
an early step of the retrieval pathway as observed by the accumulation and stabilization of misfolded proteins in subcompartments associated with the ER.

Results
KHN is a misfolded protein retrieved from the Golgi
apparatus for ERAD
Viral membrane proteins are excellent models to study protein folding and ER quality control (Gething et al., 1986;
Machamer et al., 1990; Hammond and Helenius, 1994). To
better understand quality control mechanisms, we sought to
combine their advantages with the facile genetics of the budding yeast S. cerevisiae. We selected the simian virus 5 hemagglutinin neuraminidase (HN), since its folding state can
be monitored using established methods (Ng et al., 1989).
To express HN, we replaced the HN signal/anchor domain
with the cleavable signal sequence from the yeast Kar2 protein and placed the fusion construct downstream of the moderate yeast PRC1 (CPY) promoter. This was done to bypass
the poor utilization of the endogenous signal/anchor domain
in yeast (unpublished data). The resulting protein, designated KHN, is similar to a soluble version of HN characterized previously in mammalian cells (Parks and Lamb, 1990).
We monitored the expression of KHN by metabolic pulse–
chase analysis and made an unexpected observation. As shown
in Fig. 1 A, KHN is lost rapidly after a 30-min chase and is
nearly undetectable by 60 min. Since proteins from both cells
and medium were combined for immunoprecipitation, secre-

Figure 1. KHN is a rapidly degraded protein that is transported to
the Golgi apparatus. (A) Wild-type and cue1 cells expressing KHN
were metabolically pulse-labeled at 30C with [35S]methionine/
cysteine for 10 min followed by a cold chase for times indicated.
KHN was immunoprecipitated from detergent lysates using anti-HN
polyclonal antiserum and resolved by electrophoresis on a 10% SDS
polyacrylamide gel. Where indicated, N-linked carbohydrates were
removed by incubation of immunoprecipitated proteins with 500 U
endoglycosidase H (Endo H) for 3 h. The positions of proteins
immunoprecipitated nonspecifically are indicated by asterisks. (B)
Wild-type, pmt1, and pmt2 cells expressing KHN were analyzed
as described for A. (C) Wild-type, sec12–4, and sec18–1 cells
expressing KHN were grown to log phase at 22C and shifted to 37C.
After 30 min, the cells were pulse-labeled and chased for the times
indicated. KHN was immunoprecipitated and analyzed as described
for A. The positions of the KHN p1 and p2 forms are indicated (A),
and arrows mark the position of the p1 form (B and C).
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tion of KHN was ruled out to account for the loss. Alternatively, as a foreign protein KHN may fail to properly fold and
be subject to quality control mechanisms leading to its degradation. Consistent with this notion, KHN fails to form disulfidelinked dimers and is not reactive to conformation-dependent
anti-HN monoclonal antibodies (unpublished data). In a strain
deleted of CUE1, a gene required for ubiquitination of proteins
destined for ERAD (Biederer et al., 1997), KHN appeared to
be stabilized during the same time course (Fig. 1 A, middle).
We confirmed KHN as a bona fide ERAD substrate, since it is
stabilized by multiple ERAD-specific mutants (see below). Interestingly, stabilization of KHN enhanced an unexpected characteristic for an ERAD substrate, that is, a time-dependent decrease in gel mobility (Fig. 1 A, p1 and p2). We next explored
the nature of the altered forms.
Stepwise increases in molecular weight are commonly observed during the maturation of many yeast secretory pathway proteins. The increase is due to elaboration of carbohydrates attached initially in the ER (Herscovics and Orlean,
1993). The delay reflects the time needed to transport nascent polypeptides to the Golgi apparatus where the modifying enzymes reside (Gemmill and Trimble, 1999; StrahlBolsinger et al., 1999). With this in mind, the observed
modification raised the intriguing possibility that KHN is
transported to the Golgi and retrieved to the ER for degradation. We addressed this possibility by first determining

whether the shifts are actually due to carbohydrate modification. Endoglycosidase H digestion was used to remove
N-linked carbohydrates from KHN. If the gel mobility shifts
were due solely to modification of N-linked sugars, all forms
of KHN after endoglycosidase H treatment would migrate
equally. As shown in Fig. 1 A (right), removal of N-linked
sugars did not eliminate the mobility differences. We next
tested for O-linked carbohydrates by using mutants specifically defective at the first step of O-mannosylation. O-mannosylation begins in the ER with the transfer of a single
mannose residue from Man-P-dolichol to the polypeptide.
Enzymes of the protein mannosyltransferase (PMT) family
catalyze this reaction. Strains deleted of individual PMT genes
exhibit substrate-specific defects in glycosylation, reflecting
the nonredundant nature of these genes (Gentzsch and Tanner, 1996). We expressed KHN in strains singly deleted of
each PMT family member (PMT1–PMT6). As shown in Fig.
1 B, strains deleted of PMT1 and PMT2 prevented KHN
mobility shifts such that p1 remained the predominant form
that is degraded eventually. These data show that KHN
O-glycosylation is dependent on PMT1 and PMT2 whose
products were shown previously to work together as a complex (Gentzsch et al., 1995). KHN processing was unaffected
in strains singly deleted of PMT3-PMT6 (unpublished data).
Proteins O-mannosylated in the ER are usually modified
through lengthening of the carbohydrates in the Golgi (LusFigure 2. KHNt is a substrate for
degradation by the ERAD pathway. (A)
Wild-type and mutant strains expressing
KHNt were pulse-labeled for 10 min with
[35S]methionine/cysteine and followed by
a cold chase as indicated. Immunoprecipitation of KHNt was performed using
anti-HA monoclonal antibody (HA.11;
BabCo) and normalized by total TCA
precipitable counts. Proteins were
analyzed by SDS-PAGE and visualized by
autoradiography. (B) The experiments
described for A were quantified by
PhosphorImager analysis using the same
gels that generated the autoradiograms
shown in A. (C) Relative steady-state
levels of KHNt in wild-type and ERAD
mutants were analyzed by immunoblotting. Equal amounts of cell lysate (0.2
OD600 equivalents of cells) were loaded
in each lane, separated by electrophoresis,
transferred to nitrocellulose, and probed
using HA.11 monoclonal antibody.
Proteins were visualized using chemiluminescence (Pierce Chemical Co.). (D)
Immunolocalization of KHNt in wild-type
and ERAD mutant cells were performed
using fixed and permeabilized cells on
glass slides. KHNt and BiP were detected
using -HA monoclonal antibody and
-Kar2p polyclonal antiserum, respectively. After binding of fluorescent
secondary antibodies, KHNt was visualized in the red channel (a, b, and c),
and BiP was visualized in the green
channel (d, e, and f). In each channel,
images were captured using identical
exposure times. Bar, 2 m.
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sier et al., 1997). To test whether the KHN gel mobility
shift is due to post-ER processing, we expressed KHN in the
well-characterized ER-to-Golgi transport mutants sec12–4
and sec18–1 (Eakle et al., 1988; Nakano et al., 1988; Barlowe and Schekman, 1993). When transport is blocked in
these strains, KHN remains in the p1 form over an extended
time course (Fig. 1 C). This is consistent with formation of
the p2 form in the Golgi apparatus where the modifying enzymes reside. From these data, we designate the ER form as
p1 and the Golgi form as p2. Interestingly, the turnover of
KHN appears to be impaired in these mutants, suggesting
that transport out of the ER may be a required step for degradation. Unfortunately, nonspecific immunoprecipitation
of proteins overlapping the p1 and p2 forms made the kinetics of KHN turnover difficult to measure. Thus, the extent
of the stabilization was inconclusive from these experiments.
To accurately measure the kinetics of KHN turnover, a
modified version was constructed bearing a COOH-terminal triple HA epitope tag (KHNt). When using the anti-HA
monoclonal antibody, immunoprecipitations of KHNt were
free of background, and the yields were otherwise indistinguishable from experiments using the anti-HN polyclonal
antisera (Fig. 2 A; unpublished data). KHNt is modified and
degraded similarly to KHN except that the rate of turnover
seems to be reduced slightly (Fig. 2 A, top, compared with
Fig. 1 A, left). Although preliminary results suggested that
KHN might be a substrate of the ERAD pathway, its transport to the Golgi raised the possibility that a fraction might
continue forward and degrade in the vacuole (the yeast
equivalent of lysosomes). This was ruled out when KHNt
was degraded similarly to wild type in a mutant deficient in
functional vacuolar proteases (Fig. 2, A and B, pep4). To
establish firmly that KHN is a substrate of ERAD, we measured the stability of KHNt in several mutants defective specifically in the pathway. As shown in Fig. 2, when KHNt is
Figure 3. ER-to-Golgi transport is
required for degradation of soluble but
not membrane-bound ERAD substrates.
(A–D) Wild-type and ER transport mutant
strains sec12–4 and sec18–1 expressing
HA-tagged ERAD substrates were grown
to log phase at 22C and shifted to the
restrictive temperature of 37C for 30
min. Time courses were performed and
analyzed as described in the legend to
Fig. 2. The data is plotted to compare
rates of degradation for each substrate
in various strain backgrounds. A cue1
strain was included as a positive control
for Ste6–166p and Sec61–2p.

expressed in strains deleted of the CUE1 (role in ubiquitination by anchoring Ubc7p to the ER membrane), DER1 (encodes an ER membrane protein required for ERAD), or
HRD1/DER3 (encodes an ER-localized E3 ubiquitin ligase)
genes, its degradation is impaired to the extent similar to
other established ERAD substrates (Hampton et al., 1996;
Knop et al., 1996; Biederer et al., 1997; Bordallo et al.,
1998). Western blot analysis shows the steady-state accumulation of higher molecular weight (p2) forms of KHNt in
each of the mutants, confirming that it is these species that
are preferentially degraded in wild-type cells (Fig. 2 C).
Misfolded proteins accumulate in the ER of cells defective
for ERAD functions (Knop et al., 1996; Loayza et al.,
1998). Since KHNt is transported to the Golgi before degradation, we wondered where it accumulates when ERAD is
disrupted. By performing indirect immunofluorescence, we
found that KHNt also accumulates in the ER of ERAD mutant cells as shown by its colocalization with the ER marker
BiP (Fig. 2 D). These data show that KHNt behaves similarly to some established ERAD substrates and point to the
possibility of a retrieval pathway for its degradation.
Two distinct mechanisms for the quality control of
proteins destined for ERAD
The expression of KHN in ER-to-Golgi mutants led to an
unexpected observation—transport may be an obligatory
step for its degradation. This was surprising since other
ERAD substrates, including mutant Ste6p and Yor1p, were
observed to degrade normally under the same conditions
Loayza et al., 1998; Katzmann et al., 1999). The apparent
contradiction could be resolved if different mechanisms exist
to target aberrant proteins for degradation: a static (nonrecycling) ER retention mechanism for proteins like Ste6p and
Yor1p (both integral membrane proteins) and a transport
and retrieval mechanism for others like KHN. To test this
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possibility, we applied complementary in vivo and in vitro
approaches to assess the fate of substrates before degradation.
First, we examined the effect of preventing ER-to-Golgi
transport. It was reported that the ERAD substrate Ste6–166p
is degraded in a sec18 mutant, suggesting that ERAD functions normally even if transport is blocked (Loayza et al.,
1998). We confirmed the observation in both sec12 and sec18
cells by finding the stability of Ste6–166p is identical to wild
type (Fig. 3 A). As a control, we showed that an ERAD defective mutant stabilizes Ste6–166p under the same conditions
(Fig. 3 A). We also analyzed Sec61–2p, another membrane
protein subject to ERAD (Sommer and Jentsch, 1993; Biederer et al., 1996). Since Sec61p itself plays a role in ERAD,
Sec61–2p was expressed ectopically and distinguished from
wild type with an HA epitope tag. As with Ste6–166p, Sec61–
2p is degraded normally under the restrictive conditions in
each strain (Fig. 3 B). By contrast, the degradation of KHNt
was strongly impaired (Fig. 3 C). Since core ERAD functions
are normal in these strains, the defect is likely a consequence
of perturbing the KHNt trafficking pattern that precedes degradation. We wondered whether this requirement is unique to
KHNt or reflects a more general feature of ER quality control.
For this, we examined an HA epitope–tagged version of another well-characterized soluble substrate, CPY* (Finger et al.,
1993). Although it is well established that CPY*HA uses the
core ERAD machinery, it was unclear whether it is retained or
undergoes a retrieval cycle. As shown in Fig. 3 D, CPY*HA is
stabilized strongly in both sec12 and sec18 mutants, suggesting
that it too is dependent on the vesicular transport pathway.
However, we were somewhat surprised with the effect of these
mutants, since it was reported previously that CPY* is degraded in a sec18 mutant (Finger et al., 1993). There, the degradation was most pronounced after a long chase period of
3 h. We also observed some degradation in the transport mutants so we might expect a substantial fraction of the substrate
to be degraded if we applied a similarly extended chase.
Figure 4. Soluble ERAD substrates are
contained in COPII vesicles. Recon
stituted COPII budding reactions were
performed on ER membranes isolated
from wild-type strains expressing KHNt
(A), CPY*HA (B), and Ste6–166p (C).
Lanes labeled T represent one tenth of
the total membranes used in a budding
reaction, minus () lanes indicate the
amount of vesicles formed in the
absence of the purified COPII components, and plus ( ) lanes indicate
vesicles produced when COPII proteins
are added. Total membranes and
budded vesicles were collected by
centrifugation, resolved on a polyacrylamide gel, and immunoblotted for
indicated proteins. The amount of
glyco-pro--factor (gpf) was detected
using fluorography.

The data suggest two classes of ERAD substrates, one
uses the vesicular trafficking machinery for quality control
and the other depends on static ER retention. This distinction predicts that sorting takes place in the ER to segregate
misfolded proteins to be transported from those to be retained. The differences in degradation rates in the sec12 and
sec18 mutants provided only suggestive evidence and did
not rule out the possibility of indirect effects. To test the
hypothesis directly, we performed in vitro assays that reproduce COPII-coated vesicle budding and cargo selection
from ER membranes (Barlowe et al., 1994). For these experiments, microsomes were prepared from wild-type
strains expressing KHNt, CPY*HA, and Ste6–166p. COPII
budded vesicles from these microsomes were isolated, and
the level of individual proteins packaged into vesicles were
monitored by immunoblots (Fig. 4). The efficiency of incorporation for each protein was calculated as a percentage
of the total by densitometry. For KHNt and CPY*HA, we
found both proteins packaged into COPII vesicles at 1–2%,
whereas the negative control Sec61p was not packaged.
Although the amount of misfolded proteins packaged in
COPII vesicles is less relative to other secretory proteins, it
is consistent with the slower transport of KHNt compared
with other cargo proteins (see Fig. 6 B). For the analysis of
KHNt and CPY*HA by this method, membranes were
treated with trypsin to ensure detection of protease-protected luminal species. These data provide independent
confirmation that a subset of proteins destined for ERAD
are first exported from the ER using the standard membrane trafficking machinery.
Next, we examined Ste6–166p. There already exists evidence that Ste6–166p is targeted for degradation using an
ER retention mechanism (Loayza et al., 1998). However,
the nature of the retention was unclear. When we applied
the ER vesicle budding assay to Ste6–166p, we found it remained exclusively in ER membranes even as other integral
membrane proteins were incorporated efficiently into
COPII-coated vesicles (Fig. 4 C). These data show that the
plasma membrane protein Ste6p, when misfolded, is retained in the ER by exclusion from transport vesicles. Together, these results reveal a novel facet of ER quality control. As part of its surveillance mechanism, the cell sorts
misfolded proteins for ER retention or transport.
After transport to the Golgi, degradation of KHNt and
CPY*HA by ERAD would require retrograde trafficking to
the ER. The reverse flow of membranes and proteins from
the Golgi is driven by the formation of coated vesicles of the
COPI class. To examine whether the trafficking of misfolded proteins use COPI-coated vesicles, we expressed
KHNt and CPY*HA in the -COP mutant sec21–1 and measured their turnover. At the permissive temperature of
30C, where forward transport is unaffected and retrograde
transport is little affected (Letourneur et al., 1994), we observed a small but reproducible delay in KHNt and CPY*HA
degradation (unpublished data). However, at the semipermissive temperature of 33C, which partially disrupts retrograde transport with only a minor delay in forward transport (Letourneur et al., 1994), degradation of both proteins
is inhibited (Fig. 5, A and B). We confirmed the proficiency
of forward transport by analyzing endogenous CPY (unpub-
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Figure 5. Degradation of KHNt and CPY*HA but not Ste6–166p
requires Golgi-to-ER transport. Pulse–chase analysis was performed
on wild-type and sec21–1 strains expressing (A) KHNt, (B) CPY*HA,
and (C) Ste6–166p as described in the legend to Fig. 2 except that
strains were grown to log phase at 22C and pulse-labeled immediately after a shift to 33C. Incubation at 33C was continued for the
cold chase (times as indicated). Gels were visualized by autoradiography (left) and quantified by PhosphorImager analysis (right). In C,
the gel images were from PhosphorImager scans.

lished data) and the formation of the KHNt p2 Golgi form
(Fig. 5 A). We also ruled out indirect effects on ERAD
function, since Ste6–166p degradation is normal in sec21–1
cells (Fig. 5 C). Taken together, these data demonstrate that
misfolded proteins are sorted for ER retention or transport
and retrieval from the Golgi. Ultimately, both pathways
converge in the ER for degradation by the ERAD pathway.
A gene required for ER quality control early in the
retrieval pathway
Recent studies have demonstrated that some cargo proteins
leaving the ER are actively sorted into transport vesicles
(Muniz et al., 2001). Although the molecular mechanisms
of these sorting events are not well understood, specific
genes have been implicated for the transport of just a subset
of proteins (Belden and Barlowe, 1996; Muniz et al., 2000).
Since KHNt and CPY*HA may represent a new class of cargo
proteins, we wondered whether dedicated factors function to
sort and package misfolded proteins into transport vesicles.
To address this question, we employed a genetic approach.
If such factors exist, we reasoned that their loss of function
would cause the retention and stabilization of misfolded

proteins normally transported out of the ER. We reported
previously a genetic screen based on synthetic lethality with
the unfolded protein response pathway as a powerful means
of identifying genes associated with ER quality control (Ng
et al., 2000). As the original screen was far from exhausted,
we expanded the scope with the intent of dissecting the ER
retention and recycling mechanisms of quality control. Although the details of the genetic screen will be presented
elsewhere (unpublished data), we report here the discovery
of a gene needed for the anterograde transport of misfolded
proteins in the retrieval pathway.
Starting with a pool of 152 recessive protein processing in
the ER (per) mutants, those exhibiting general processing
defects of normal proteins including glycosylation and transport were excluded (Ng et al., 2000). Of the remaining 107,
we analyzed ERAD activity by measuring the stability of
CPY*HA and Sec61–2p as described in the legend to Fig. 3.
Although still in progress, of the mutants showing defects in
only CPY*HA degradation we began analyzing the stability
and processing of KHNt. For one mutant, per17–1, both
KHNt and CPY*HA are defective for degradation (Fig. 6 A).
However, unlike other ERAD mutants (Fig. 2), KHNt remains in the ER p1 form in per17–1 cells consistent with a
transport block to the Golgi (Fig. 6 B, top). Gas1p (Fig. 6 B,
bottom) and chitinase (unpublished data) carbohydrate processing in per17–1 cells is normal and serves to control for
functional O-mannosylation and modification in per17–1
cells (Nuoffer et al., 1991; Gentzsch and Tanner, 1996).
This shows that the prevalence of the KHNt p1 form reflects
a transport defect rather than an indirect effect on glycosylation. Interestingly, transport of folded cargo proteins
showed differential effects. CPY transport was similar to
wild type, whereas Gas1p was slower than normal (Fig. 6 B).
Since Gas1p is anchored in the membrane, we examined
two additional integral membrane cargo proteins, carboxypeptidase S (CPS) and alkaline phosphatase (ALP) (Cowles
et al., 1997; Spormann et al., 1992). As shown in Fig. 6 C,
both proteins are transported indistinguishably to wild type,
confirming that the per17–1 mutation does not cause general defects in ER-to-Golgi transport.
The data suggest that the per17–1 mutation inhibits degradation by failing to promote the transport of misfolded proteins destined for the retrieval pathway. To reinforce this
view, we analyzed the fate of ERAD substrates that are sorted
for ER retention. If PER17 plays such a distinct role in ER
quality control, we expect the retention pathway to be functional and these substrates to turn over normally in per17–1
cells. As shown in Fig. 6 A (bottom), Ste6–166p and Sec61–
2p are degraded with wild-type kinetics in per17–1 cells.
These data show that the per17–1 allele is specific to the recycling pathway and validates our genetic strategy. Although
these data are similar to those obtained using the sec12 and
sec18 mutants, they extend the evidence that transport is an
important step for degradation, since the per17–1 transport
block affects misfolded soluble proteins while leaving the
transport of several normal cargo proteins intact.
To better understand the nature of the per17–1 transport
block, we performed indirect immunofluorescence to localize
KHNt and CPY*HA stabilized in per17–1 cells. As shown in
Fig. 7, both KHNt and CPY*HA are concentrated within
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Figure 6. per17–1 is a mutant specific to the
retrieval pathway, which blocks the transport of
misfolded proteins but not properly folded
proteins. (A) The turnover of KHNt, CPY*HA,
Ste6–166p, and Sec61–2p in wild-type and
per17–1 cells were measured by metabolic pulse–
chase analysis as described in the legend to Fig. 2.
Experiments were performed at 30C except for strains expressing Sec61–2p. Strains expressing Sec61–2p were grown to log phase at 30C,
shifted to 37C for 30 min, and continued for the pulse–chase. (B) Autoradiograms generated from gels of the KHNt time course shown in part
A are shown at the top. The positions of the p1 (ER) and p2 (Golgi-modified) forms are indicated. Endogenous CPY and Gas1p were immunoprecipitated in parallel from aliquots of lysates prepared from the KHNt time course. The proteins were separated by gel electrophoresis and
visualized by autoradiography (P1, ER proCPY; P2, Golgi proCPY; mCPY, mature CPY; ER Gas1p, ER form of Gas1p; mGas1, mature Golgimodified Gas1p). (C) Wild-type and per17–1 cells were pulse labeled for 10 min and chased for times indicated. CPS and ALP were immunoprecipitated and analyzed by gel electrophoresis followed by autoradiography. The pro (proCPS and proALP) and mature (mCPS and mALP)
forms of each protein are indicated.

punctate structures throughout the cell. This differs from
transport competent ERAD mutants, since they accumulate
these substrates diffusely throughout the ER (Knop et al.,
1996; Fig. 2 D). Interestingly, the punctate distribution is
reminiscent of the pattern observed for cargo proteins
blocked for transport in sec12 mutant cells (Nishikawa et al.,
1994). In those cells, the ER chaperone BiP colocalized with
cargo proteins at discrete sites within the ER. Since the misfolded proteins are similarly blocked for transport, we also ex-

amined the distribution of BiP in the per17–1 cells. As shown
in Fig. 7, BiP was found in the same punctate structures as
KHNt and CPY*HA (Fig. 7 A, b and e). Although BiP is
widely used as a marker for ER morphology, we wondered
whether the pattern reflected subdomains of the ER as the
case in sec12 cells or a general reorganization of ER membranes. To address this, we chose an alternative ER marker,
the signal recognition particle receptor  subunit (SR). SR
is an integral membrane protein that is distributed through-

Figure 7. Immunolocalization of misfolded proteins in per17–1 cells.
(A) per17–1 cells expressing KHNt (a–c) and CPY*HA (d–f) and der1
cells expressing CPY*HA (g–i) were fixed and permeabilized from
logarithmic cultures. The cells were stained with -HA and -Kar2p
antibodies followed by Alexa Fluor 546 goat -mouse (a, d, and g) and
Alexa Fluor 488 goat -rabbit (b, e, and h) secondary antibodies. Staining with DAPI (c, f, and i) indicates the positions of nuclei. Arrows mark
specific points of colocalization. (B) Wild-type and per17–1 cells expressing HA epitope–tagged SR were processed and bound to primary antibodies as in A. Alexa Fluor 546 goat -rabbit and Alexa Fluor 488 goat -mouse were used such that BiP was visualized in the red channel (a and d),
whereas SR was visualized in the green channel (b and e). Bars, 2 M.
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out the ER (Ogg et al., 1998). As shown in Fig. 7 B, SR
staining in per17–1 cells is similar to wild type, indicating that
there are no gross changes in ER morphology (Fig. 7 B, e).
This is in good agreement with ultrastructural analysis performed with the same strains (unpublished data). In doublelabel experiments, the punctate structures are always coincident with the ER as defined by SR (Fig. 7 B). These data
show that misfolded proteins accumulate with BiP at distinct
ER sites in per17–1 cells. Whether BiP forms a complex with
the misfolded proteins at these sites remains to be shown.
We next determined the identity of the PER17 gene. A
yeast genomic library based on the centromeric YCp50 vector
was transformed into the per17–1 mutant. By restoration of
the sectoring phenotype, a complementing clone was obtained (Ng et al., 2000). Through deletion mapping, a single
ORF encoding the BST1 (bypass of sec thirteen) was identified as the PER17 gene. We were intrigued, since BST1 encodes an ER integral membrane protein first cloned through
genetic interaction with SEC13, a component of the COPII
vesicle coat (Elrod-Erickson and Kaiser, 1996). Thus, BST1 is
believed to play a role in ER-to-Golgi transport. However, its
precise role was unclear, since a BST1 gene deletion did not
seem to affect the transport of two prototypic cargo proteins,
CPY and invertase. Our data suggest a novel function for
BST1 in ER quality control. Since per17–1 and bst1 cells
prevent the transport of misfolded but not most properly
folded proteins, the data suggest a role in cargo protein sorting (Fig. 6 B; unpublished data). Interestingly, the exhaustive
genetic screen that previously identified BST1 also identified
EMP24 and ERV25 (Elrod-Erickson and Kaiser, 1996).
EMP24 and ERV25 are members of the p24 family of integral
membrane proteins believed to be involved in cargo protein
sorting (Kaiser, 2000). However, they appear to function differently than BST1, since the transport and degradation of
both KHNt and CPY*HA occur normally, if not slightly accelerated, in strains deleted of those genes (unpublished data).

In this paper, we report the collaboration of two distinct
mechanisms to assure the quality control of protein biosynthesis in the yeast secretory pathway. By combining
biochemical and genetic approaches, we reconfirm the retention mechanism while uncovering another that uses
established ER-to-Golgi vesicle transport and retrieval pathways (Fig. 8). The dual mechanistic nature of ER quality
control may have evaded characterization, since both pathways converge at the degradation step and a block there results in the steady-state accumulation of substrates in the
ER. However, several studies have hinted that vesicle trafficking mechanisms might have a role in quality control. It
was observed that CPY* can acquire 1,6-mannose in a
strain deleted of the DER1 gene. 1,6-mannose is a carbohydrate modification that occurs only in the Golgi apparatus, suggesting a transport mechanism. However, since only
a small fraction was affected and the modification was not
detected in wild-type cells, it was concluded that the majority of CPY* is retained, but some can leave in DER1-deleted
cells (Knop et al., 1996). More recently, during the prepara-

Discussion
A cellular surveillance system that monitors the folding state
of nascent proteins in the ER was first observed nearly a
quarter century ago. Those pioneering studies showed that
viral membrane proteins, when misfolded, were not transported to the plasma membrane but retained at the site of
synthesis (Gething et al., 1986; Kreis and Lodish, 1986).
Subsequently, the phenomenon was appropriately termed
“ER quality control” and led to the realization that several
human diseases, including cystic fibrosis, owed their molecular basis to the retention and degradation of mutant proteins (Carrell and Gooptu, 1998; Kim and Arvan, 1998; Kopito and Ron, 2000). More recently, important strides have
improved our understanding of ER quality control. Most
notably, the degradation step, or ERAD, is now known to
involve the retrotranslocation of substrates to the cytosol
through the ER translocon pore (Wiertz et al., 1996; Pilon
et al., 1997; Plemper et al., 1997; Zhou and Schekman,
1999). During or after retrotranslocation, substrates are
ubiquitinated and degraded by the 26S proteasome (Ward et
al., 1995; Hiller et al., 1996). Despite these advances, the
events upstream to ERAD remained unclear.

Figure 8. Proposed model of ER quality control in budding yeast.
After translocation, proteins that misfold are sorted for the retention
pathway (white arrows) or the retrieval pathway (black arrows). In
the retrieval pathway, proteins are packaged into COPII vesicles,
transported to the Golgi apparatus, and retrieved via the retrograde
transport pathway. In the ER, substrates of both pathways converge
for ERAD. The proteins cross the ER membrane via the translocon
complex, marked by ubiquitination and degraded by the cytosolic
26S proteasome.
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tion of this article a paper available electronically reported
that ERAD substrates show retarded degradation rates in
ER-to-Golgi transport mutants (Caldwell et al., 2001). Although in agreement with our findings, no direct evidence
was presented that misfolded proteins are transported as part
of their degradative pathway. Here, we provide direct evidence of ER-to-Golgi transport of misfolded proteins in vivo
and in vitro and a requirement for retrograde transport.
Key to our approach was the characterization of KHN as a
novel ERAD substrate. Unlike other misfolded proteins
commonly studied, KHN allows the use of O-linked sugar
modifications to monitor its transport (Fig. 1). The native
HN protein is not O-glycosylated in mammalian cells so it
seems likely that the modifications are due to promiscuous
O-mannosylation that can occur when proteins misfold in
yeast (Harty et al., 2001). The processing of these carbohydrates shows that most, if not all, of the protein uses a retrieval mechanism before ERAD. Furthermore, we found
that disruption of either forward or retrograde transport
compromised KHN degradation. The transport requirement
is not peculiar, since the well-characterized substrate CPY* is
affected similarly under all circumstances. Since substrates
subject to retention are degraded normally in these mutants,
the data strongly suggest that transport and retrieval are
obligatory steps for efficient KHN and CPY* degradation.
An in vitro vesicle budding assay using purified components provided direct evidence that KHN and CPY* are
packaged into COPII-coated vesicles, whereas Ste6–166p is
excluded. These experiments were important, since the assay
was established previously to reflect early events in ER-toGolgi transport. Although the data serve to confirm and extend the in vivo experiments, they also reveal a novel ER
sorting mechanism for misfolded proteins at or just before
the formation of COPII vesicles. The retrieval pathway
largely uses the standard vesicle transport machinery, but we
do not know whether misfolded proteins occupy the same
vesicles as folded cargo proteins. Recently, it was shown that
different classes of folded cargo proteins occupy distinct vesicle populations (Shimoni et al., 2000; Muniz et al., 2001).
Thus, it seems possible that misfolded proteins are sorted
into specialized vesicles for transport to the Golgi.
The retention and retrieval mechanisms appear to be
highly selective. Of the substrates examined, each used only
one pathway. This raises the important question of what
specific structural features determine selection of substrates
into their respective pathways. Although we examined only
four substrates for this study, we propose for most substrates
membrane proteins are retained, whereas soluble proteins
are retrieved. Although the appeal is obvious from a mechanistic point of view, there already exists a possible exception.
A mutant form of pro--factor, a soluble protein, was degraded in vitro using purified ER microsomal membranes
(McCracken and Brodsky, 1996). The lack of Golgi membranes in the assay suggested that a vesicle transport pathway
is not required. Although these studies suggest retention,
mutant pro--factor may represent a distinct mechanism altogether, since it does not require ubiquitination for degradation in vitro and differs from CPY* in its requirements for
chaperones (Werner et al., 1996; Nishikawa et al., 2001).
Therefore, alternative strategies to those described here are

probably needed to clear all forms of aberrant proteins from
the ER.
Recently, it became clear that the unfolded protein response (UPR) pathway plays an important role in regulating
ERAD (Casagrande et al., 2000; Friedlander et al., 2000;
Ng et al., 2000; Travers et al., 2000). It was gratifying to
learn that an ER signaling pathway sensitive to the accumulation of misfolded proteins plays a direct role in ridding
them. By whole genome microarray analysis, it was also
found that many genes of the secretory pathway are UPR
targets including those involved in retrograde transport from
the Golgi (Travers et al., 2000). The significance of these
target genes in UPR function was unclear previously. A retrieval mechanism for ERAD substrates provides a logical
physiological basis for their regulation. However, it remains
to be tested whether induction of these specific genes by the
UPR is required for the correct processing of ERAD substrates during periods of ER stress.
A retrieval mechanism adds layers of complexity to our
current view of ER quality control and raises numerous new
questions. First, misfolded proteins are sorted in the ER for
transport or retention. How is that achieved? For misfolded
membrane proteins, there is evidence of retention factors.
Mutants of the plasma membrane ATPase Pma1p are retained and degraded in the ER. Chang and coworkers reported a genetic approach that uncovered a protein disulfide
isomerase-related protein, Eps1p, needed to prevent the
transport of mutant Pma1p (Wang and Chang, 1999). In
light of our results, their data suggest retention to be an active process using specific factors to restrict the partitioning
of proteins into transport vesicles. What role Eps1p plays in
this process is currently unknown. Similarly, our genetic
analysis of the retrieval pathway suggests an active mechanism for recognition and transport. In the absence of BST1
function, KHN and CPY* are retained and stabilized in the
ER, whereas the retention pathway substrate Ste6–166p is
degraded normally (Fig. 6). Since BST1 is not essential for
the transport of most folded cargo proteins examined, the
data suggest a possible role in cargo protein sorting. In support of this hypothesis, a genetic link was found between
BST1 and SEC13, a gene encoding a component of COPII
vesicle coats (Elrod-Erickson and Kaiser, 1996). Experiments are in progress to directly test the assertion. In addition to per17 alleles, other mutants with similar phenotypes
were isolated from our genetic screen, suggesting the collaboration of other factors at this early step (unpublished data).
Although the precise function of BST1 is unclear currently, we have performed additional experiments that reinforce its vital role in ER quality control. The unfolded
protein response activates in response to the accumulation
of misfolded proteins in the ER (Kozutsumi et al., 1988).
We observed that loss of BST1 function strongly induces
the UPR in the absence of ectopically expressed proteins
(unpublished data). We interpret the response to reflect
the accumulation of endogenous misfolded proteins that
normally depend on BST1 for degradation. Furthermore,
in contrast to other ERAD mutants examined in this study
the viability of BST1 mutants is hypersensitive to the overexpression of misfolded proteins (unpublished data). This
effect suggests a role at a physiologically important point
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in ER quality control. Taken together, BST1 represents a
new class of genes for ER quality control. It acts in the retrieval pathway far upstream the point of convergence for
both pathways.
Although both pathways converge at the translocon for retrotranslocation and degradation, the events just preceding
this last step are unclear. Since it is essentially a protein translocation mechanism, established paradigms may serve to
guide future studies and have been discussed eloquently in a
recent essay (Johnson and Haigh, 2000). In typical translocation pathways across membranes, nascent polypeptides contain signal sequences recognized by specific targeting factors.
For retrotranslocation of misfolded proteins, it is unlikely
that signal sequence motifs will be found, since they would
also exist on newly synthesized proteins. In mammalian cells,
the ER lectins calnexin and calreticulin bind to carbohydrates of incompletely folded proteins and thus may serve as
potential targeting factors (Hauri et al., 2000). Indeed, specific N-linked carbohydrate moieties are necessary for the
degradation of CPY* in yeast (Jakob et al., 1998). In experiments comparing the carbohydrate requirements of KHN
and CPY*, inhibition of O-mannosylation reduces the rate
of degradation for KHN but has no effect on CPY* (unpublished data). It is conceivable that Golgi modification of
KHN O-mannosylated residues signals its degradation upon
return to the ER. We are currently exploring this possibility.
Despite these examples, there are numerous substrates that
are not glycosylated but nevertheless degraded efficiently by
ERAD (Sommer and Jentsch, 1993; Biederer et al., 1996;
McCracken and Brodsky, 1996; Loayza et al., 1998). Thus,
carbohydrates may play differential roles depending on the
specific substrate but cannot serve as general signals. Alternatively, molecular chaperones are known to bind exposed hydrophobic domains on the surfaces of misfolded proteins.
With this, they are qualified to be general targeting factors
that bring substrates to the translocon. The ER chaperone
BiP could serve such a role, since it is required for ERAD
and can interact directly with Sec63p, a component of the
translocon (Brodsky and Schekman, 1993; Plemper et al.,
1997; Brodsky et al., 1999). Since BiP binds to nascent
polypeptides, the cell must be able to distinguish proteins in
the process of folding from those that cannot fold. The retrieval pathway may provide the means to partition misfolded proteins destined for ERAD from those in the process
of folding. Our data are consistent with an active sorting
mechanism to transport misfolded proteins out of the ER.
Although just one of many possible scenarios, misfolded proteins may be returned to the regions of the ER specialized for
ERAD. Although this notion is highly speculative, in sec12
and per17–1 mutants misfolded proteins are retained in the
ER. However, the proteins are degraded very poorly, and we
find that the proteins are in distinct regions of the ER (Fig.
7; unpublished data). Since retention pathway substrates are
degraded efficiently in these mutants, it seems possible that
the defect is attributable to their aberrant localization.
The delineation of two separate mechanisms for ER quality control raises far more questions than are answered. The
distinction is still important, since it impacts the experimental designs of future studies in ER quality control. Already,
we have applied the principles to our genetic approaches to

identify mutants and genes specific to the retention and retrieval mechanisms and after their point of convergence (unpublished data). By monitoring the processing of KHN, we
have also begun to dissect the mechanisms that underlie the
retrieval pathway.

Materials and methods
Plasmids used in this study
Plasmids were constructed using standard cloning protocols (Sambrook et
al., 1989). For pDN431 and pDN436, HA epitope–tagged CPY* expression
vectors were described previously (Ng et al., 2000). For pSM1083 and
pSM1346, HA epitope–tagged Ste6–166p expression vectors were gifts from
S. Michaelis (Johns Hopkins University, Baltimore, MD) (Loayza et al., 1998).

Construction of the HA epitope–tagged Sec61–2p expression
vector pDN1002
The promoter and coding sequences of sec61–2 were cloned from strain
RSY533 (MAT, sec61–2, leu2, ade2, ura3, pep4–3) by amplification of genomic DNA using Vent polymerase (New England Biolabs, Inc.) performed
according to manufacturer’s protocol. Using the primers N182 (5 CGAATCCGTCGTTCGTCACC-3 ) and N183 (5 -TTCCCATGGAATCAGAAAATCCTGG-3 ), the amplified 2,016-bp fragment was digested with
HindIII and NcoI, and the 1,931-bp fragment was purified. The purified
fragment was ligated into pDN333 digested with the same enzymes.
pDN333 was generated by inserting the HA-tagged insert from pDN280
(Ng et al., 1996) into pRS315 (Sikorski and Hieter, 1989). An NcoI site from
N183 places the Sec61–2p coding sequence in frame with vector sequences encoding a single HA tag followed by ACT1 terminator sequences.

Construction of KHN expression vectors pSM31, pSM56,
pSM70, and pSM72
The KHN fusion gene was constructed by ligating the sequences encoding the first 45 amino acids of Kar2p (signal sequence and signal peptidase cleavage site) to the COOH-terminal 528 amino acids of the SV5
HN gene. Both fragments were amplified by PCR using Vent polymerase
and inserted into pDN251 to generate pSM31. pDN251 is identical to
the yeast expression vector pDN201 (Ng et al., 1996) except it contains
the moderate PRC1 promoter in place of the TDH3 promoter. pSM70 is
identical to pSM31 except for the addition of a triple HA epitope tag inserted in-frame to the COOH terminus of KHN. Sequences encoding the
triple HA epitope tag were excised from pCS124 (a gift from C. Shamu,
Harvard University, Cambridge, MA). pSM56 and pSM72 are similar to
pSM31 and pSM70, respectively, except that the KHN gene sequences
were subcloned into pRS315.
pES69 was constructed by inserting a NotI/KpnI fragment containing the
gene for HA epitope–tagged SR from pSO459 (Ogg et al., 1998) into
pRS426 (Sikorski and Hieter, 1989).

Strains and antibodies
Yeast strains used in this study are described in Table I. Anti-HA monoclonal antibody (HA.11) was purchased from BabCo. Anti-Kar2p antibody
was provided by Peter Walter (University of California, San Francisco, CA).
Anti-CPY antiserum was provided by Reid Gilmore (University of Massachusetts, Worcester, MA). Anti-Gas1p was a gift from Howard Riezman
(University of Basel, Basel, Switzerland). Anti-ALP and anti-CPS antisera
were gifts from Chris Burd and Scott Emr (University of California, San Diego, CA). Anti-HN antiserum was described previously (Ng et al., 1990).
Secondary antibodies labeled with Alexa Fluor 488 or 546 were purchased
from Molecular Probes, Inc.

Cell labeling and immunoprecipitation
Typically, 2 A600 OD U of log phase cells were pelleted and resuspended
in 1.0 ml of synthetic complete medium lacking methionine and cysteine.
After 30 min of incubation at the appropriate temperature, cells were labeled with 480 Ci of Tran35S-label (ICN Biomedicals). A chase was initiated by adding cold methionine/cysteine to a final concentration of 2 mM.
The chase was initiated 30 s before the end of the pulse to exhaust intracellular pools of unincorporated label. Labeling/chase was terminated by
the addition of trichloroacetic acid to 10%. Preparation of cell lysates, immunoprecipitation procedures, gel electrophoresis, and quantification of
immunoprecipitated proteins were performed as described previously (Ng
et al., 2000).
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Table I. Strains used in this study
Strain
W303a
SMY248
SMY249
SMY 250
SMY251
SMY252
SMY254
SMY258
SMY259
RSY255
RSY277
SMY359
SMY360
SMY361
SMY362
SMY390
SMY391
SMY301
SMY302
SMY303
SMY312
SY114
SY655
SY656
SY657
SY415
SY658
SY659
SMY319
SMY347
SMY313
SMY320
SMY326
SMY348
SMY349
SMY225
SMY226
SMY227
SMY228
WKY4
WKY20
WKY21
WKY23
WKY25
WKY108
WKY110
WKY135
SMY340
SMY342
SMY383
SMY384
WKY213
SMY385
SMY387

Genotype

Source

MATa, leu2-3,112, his3-11, trp1-1, ura3-1, can1-100, ade2-1
MATa, W303, pSM70
MATa, cue1::TRP1, pSM70, W303 background
MATa, der1::KANMX, pSM70, W303 background
MATa, der3::KANMX, pSM70, W303 background
MATa, per17-1, pSM70, W303 background
MAT, pep4::HIS3, pSM70, W303 background
MATa, sec12-4, pSM70, W303 background
MATa, sec18-1, pSM70, W303 background
MAT, leu2-3,112, ura3-52
MAT, sec21-1, ura3-52
MAT, RSY255, pSM70
MAT, RSY255, pDN431
MAT, RSY277, pSM70
MAT, RSY277, pDN431
MATa, RSY255, pSM1083
MATa, RSY277, pSM1083
MATa, W303, pSM31
MATa, sec12-4, pSM31, W303 background
MATa, sec18-1, pSM31, W303 background
MATa, cue1::TRP1, pSM31, W303 background
MAT, leu2-3, ura3-52, his3-200, lys2-801, trp1-90, suc2-9
MAT, pmt1::URA3, SY114 background
MAT, pmt2::LEU2, SY114 background
MAT, pmt3::HIS3, SY114 background
MAT, pmt4::TRP1, SY114 background
MAT, pmt5::URA3, SY114 background
MAT, pmt6::URA3, SY114 background
MAT, pmt1::URA3, pSM56, W303 background
MAT, pmt2::LEU2, pSM56, W303 background
MAT, SY656, pSM31
MATa, SMY237, pSM56, W303 background
MATa, SMY239, pSM31, W303 background
MATa, W303, pSM1346, W303 background
MATa, per17-1, SM1346, W303 background
MATa, W303, pSM1083, W303 background
MATa, cue1::TRP1, pSM1083, W303 background
MATa, sec12-4, pSM1083, W303 background
MATa, sec18-1, pSM1083, W303 background
MATa, sec12-4, pDN431, W303 background
MATa, per17-1, pDN436, W303 background
MATa, per17-1, pDN1002, W303 background
MATa, sec12-4, pDN1002, W303 background
MATa, sec18-1, pDN1002, W303 background
MATa, per17-1, pSM1346, W303 background
MATa, W303, pSM1346, W303 background
MATa, sec18-1, pDN436, W303 background
MATa, W303, pSM70, pSM72
MATa, per17-1, pSM70, pSM72, W303 background
MATa, der1::KANMX, pSM70, pSM72, W303 background
MATa, der3:KANMX, pSM70, pSM72, W303 background
MATa, W303, pDN436
MATa, W303, pES69
MATa, per17-1, pES69, W303 background

P. Waltera
This study
This study
This study
This study
This study
This study
This study
This study
R. Schekmanb
R. Schekman
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
S. Sandersc
S. Sanders
S. Sanders
S. Sanders
S. Sanders
S.Sanders
S. Sanders
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

a

University of California, San Francisco, CA.
University of California, Berkeley, CA.
c
Massachusetts Institute of Technology, Cambridge, MA.
b

In vitro budding assays
Vesicle budding from the ER was reproduced in vitro by incubation of microsomes (Wuestehube and Schekman, 1992) with purified COPII proteins
(Sar1p, Sec23p complex, and Sec13p complex) as described (Barlowe et
al., 1994). Microsomes were prepared from cells expressing misfolded
KHNt, CPY*HA, and Ste6–166p (SMY248, WKY114, and SMY225). To
measure incorporation of proteins into COPII vesicles, a 15-l aliquot of

the total budding reaction and 150 l of a supernatant fluid containing
budded vesicles were centrifuged at 100,000 g in a TLA100.3 rotor (Beckman Coulter) to collect membranes. The resulting membrane pellets were
solubilized in 30 l of SDS-PAGE sample buffer, and 10–15 l were resolved on 12.5% polyacrylamide gels. For measurement of KHNt and
CPY* contained in COPII vesicles, membranes were treated with trypsin
(100 g/ml) for 10 min on ice followed by trypsin inhibitor (100 g/ml) to

366 The Journal of Cell Biology | Volume 155, Number 3, 2001
ensure detection of a protease-protected species. The percentages of individual proteins (KHNt, CPY*, Ste6–166p, Bos1p, Erv25p, and Sec61p)
packaged into vesicles from a total reaction were determined by densitometric scanning of immunoblots. Protease protected [35S]glyco–pro-factor packaged into budded vesicles was measured by precipitation
with concanavalin A–Sepharose after posttranslational translocation of
[35S]-prepro--F into microsomes (Wuestehube and Schekman, 1992).
[35S]glyco–pro--factor was also visualized by PhosphorImager analysis
(Molecular Dynamics) after transfer to nitrocellulose membranes and exposure to a phosphor screen.

Indirect immunofluorescence microscopy
Cells were grown in synthetic complete medium to an OD600 of 0.5–0.9.
Formaldehyde (EM grade; Polysciences, Inc.) was added directly to the
medium to 3.7% at 30C for 1 h. After fixation, cells were collected by
centrifugation and washed with 5 ml 0.1 M potassium phosphate buffer
(pH 7.5). Cells were incubated 30 min at 30C in spheroplasting buffer (1.0
mg/ml zymolyase 20T [ICN Biomedicals], 0.1 M potassium phosphate, pH
7.5, 0.1% 2-mercaptoethanol) to digest the cell wall. Digestion was terminated by washing cells once in PBS. 30 l of cell suspension was applied
to each well of a poly-L-lysine–coated slide for 1 min and washed three
times with PBS. Slides were immersed in acetone for 5 min at –20C and
allowed to air dry. Subsequent steps were performed at room temperature.
30 l of PBS block (3% BSA in PBS) were added to each well and incubated for 30 min. Primary antibodies -HA or -Kar2p were applied and
used at 1:1,000 or 1:5,000 dilutions for in PBS block, respectively, for 1 h.
Wells were washed three to five times with PBS block. 30 l secondary antibodies (Alexa Fluor 488 goat -mouse or -rabbit and Alexa Fluor 546
goat -mouse or -rabbit; Molecular Probes, Inc.) were added to wells and
incubated for 45 min in the dark. Wells were washed five to seven times
with PBS block and two times with PBS. Each well is sealed with 5 l
mounting medium (PBS, 90% glycerol, 0.025 g/ml DAPI) and a glass
coverslip. Samples were viewed on a ZEISS Axioplan epifluorescence microscope. Images were collected using a Spot 2 cooled digital camera (Diagnostic Instruments) and archived using Adobe Photoshop® 4.0. In experiments using KHNt, two copies of the gene were introduced into each
strain to enhance detection. Low expression levels at single copy were
likely due to suboptimal codon usage of this mammalian viral gene by
yeast cells. By increasing gene dosage, the expression level was similar to
CPY*HA at single copy and had no effect on its processing as an ERAD substrate (unpublished data).
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